Back
Speaker illustration

Professor Hugh Barrett

Crawley (Australia)

Presentations

Evolocumab lowers plasma Lp(a) concentration by two kinetic modes of action: From the FLOREY Study

Event: ESC Congress 2017

Topic: Lipids

Session: Lipid metabolism

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources